Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sandra Colas
Observed names:
Colas S,
S. Colas
Institutions:
Hôpital Necker-Enfants Malades,
Université Paris Cité,
Hôpital Cochin,
Assistance Publique – Hôpitaux de Paris
Observed institutions:
Hôpital Necker-Enfants Malades,
Université Paris Cité,
Centre Hospitalier Universitaire de Bordeaux,
Hôpital Cochin,
Assistance Publique – Hôpitaux de Paris,
Hôpital Européen Georges-Pompidou,
Hôpital Saint-André,
Université Paris Descartes
show all 8
ORCID:
0000-0001-7624-6494
Observed ORCID:
0000-0001-7624-6494
OpenAlex ID:
A5072583294
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
2018
·
Arnaud Méjean
, Alain Ravaud
, et al.
·
New England Journal of Medicine
·
1,027
Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
2021
·
Arnaud Méjean
, Alain Ravaud
, et al.
·
European Urology
·
143
PDF
Cytoreductive nephrectomy (CN) in metastatic renal cancer (mRCC): Update on Carmena trial with focus on intermediate IMDC-risk population.
2019
·
Arnaud Mejean
, Simon Thezenas
, et al.
·
Journal of Clinical Oncology
·
65
VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial
2014
·
Marie Courbebaisse
, Corinne Alberti
, et al.
·
Trials
·
51
PDF
Nonskeletal and skeletal effects of high doses versus low doses of vitamin D3 in renal transplant recipients: Results of the VITALE (VITamin D supplementation in renAL transplant recipients) study, a randomized clinical trial
2023
·
Marie Courbebaisse
, Aurelie Bourmaud
, et al.
·
American Journal of Transplantation
·
48
PDF
CARMENA: Cytoreductive nephrectomy followed by sunitinib versus sunitinib alone in metastatic renal cell carcinoma—Results of a phase III noninferiority trial.
2018
·
Arnaud Mejean
, Bernard Escudier
, et al.
·
Journal of Clinical Oncology
·
16
Digenic Inheritance Mode in Congenital Hypothyroidism Due to Thyroid Dysgenesis: HYPOTYGEN Translational Cohort Study
2025
·
Athanasia Stoupa
, Dulanjalee Kariyawasam
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
5
A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease
2026
·
Dominique Joly
, Moreno Ursino
, et al.
·
Kidney International
·
1
Digenic Inheritance Mode in Congenital Hypothyroidism Due to Thyroid Dysgenesis: HYPOTYGEN Translational Cohort Study
2026
·
Stoupa A
, Kariyawasam D
, et al.
·
Yearbook of pediatric endocrinology
Absence de bénéfice extra-osseux de doses élevées de vitamine D3 chez les transplantés rénaux dans une étude prospective, multicentrique, en double aveugle, randomisée
2018
·
M. Courbebaisse
, S. Colas
, et al.
·
Néphrologie & Thérapeutique
AMGLIDIA, a Suspension of Glibenclamide for Patients with Neonatal Diabetes, Long Term Data on Efficiency and Tolerance
2018
·
Jacques Beltrand
, Candice Meyzer
, et al.
·
57th Annual ESPE
Persistent Beneficial Metabolic Effect after Five Years in a Cohort of 28 Subjects with Neonatal Diabetes owing to Potassium Channel Mutation and Transferred from Insulin to Sulfonylureas
2016
·
Marie Hoarau
, Anne-Laure Fauret
, et al.
·
55th ESPE Meeting
Show more works
View as search
Works count:
12
Citation count:
1,356
H-index:
6
I10-index:
6
Year
Topic
Type